Aerogen is attending SFMU 2022
Aerogen is attending SFMU’s Urgences Congress in Paris. We will be based at stand no. 83 from the 8th to the 10th of June.
We are the world leader in acute care aerosol drug delivery. With 20 years’ experience and 300 international patents. Aerogen® technology has been used to treat 13 million patients in 75 countries. Based on Aerogen’s vibrating mesh technology, the Aerogen® Solo has become the gold standard for respiratory patient care in hospitals from the emergency department to intensive care. Our continuity of care means that it is One system across the patient’s respiratory journey (MV, NIV, HFNC, Spontaneous breathers)(1).
If you are attending Urgences 2o22 then stop by our stand to learn more about Aerogen in the emergency department and how our products can improve your respiratory patient outcomes.
If you are not attending but would like to learn more about Aerogen then please contact marketing@aerogen.com.
We will also be attending the SRLF Congress, Reanimation from the 22nd to the 24th of June in Paris. We look forward to sharing more details surrounding our stand number and attendance and we hope to see you there.
- Aerogen Solo System Instruction Manual, 2021